New radiation strategy tested for aggressive brain cancer
NCT ID NCT01507506
First seen Apr 17, 2026 · Last updated May 21, 2026 · Updated 5 times
Summary
This study tested a new, more precise type of radiation therapy (IMRT with a special MRI-guided boost) against standard radiation, both given with the chemotherapy drug temozolomide, for people with glioblastoma, an aggressive brain cancer. The goal was to see if the newer radiation could help patients live longer. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP HM - Hôpital La Timone
Marseille, 13385, France
-
CHU de Strasbourg
Strasbourg, 67065, France
-
Centre Georges François Leclerc
Dijon, 21000, France
-
Centre Jean Perrin
Clermont-Ferrand, 63011, France
-
Centre Leon Berard
Lyon, 69373, France
-
Centre Marie Curie
Valence, 26953, France
-
Centre Paul Strauss
Strasbourg, 67065, France
-
Centre Val d'Aurelle
Montpellier, 34298, France
-
Clinique Claude Bernard
Albi, 81000, France
-
Hospices Civils de Lyon (Hôpital Lyon Sud/Hôpital P. Wertheimer)
Lyon, 69002, France
-
Institut Claudius REGAUD
Toulouse, 31052, France
-
Institut de Cancerologie Lucien Neuwirth
Saint-Priest-en-Jarez, 42271, France
Conditions
Explore the condition pages connected to this study.